Efficacy and Safety of SHR-1905 Injection in Subjects With Chronic Rhinosinusitis With Nasal Polyps

NCT07132827 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

280

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Rhinosinusitis With Nasal Polyps

Interventions

DRUG: SHR-1905 Injection
DRUG: SHR-1905 Placebo Injection

Sponsor

Guangdong Hengrui Pharmaceutical Co., Ltd